Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengwu Zhang

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
International Journal of Molecular Sciences|May 7, 2025
Environmental Factors Exacerbate Parkinsonian Phenotypes in an Asian-Specific Knock-In LRRK2 Risk Variant in MiceZoë Bichler, Sarivin Vanan, Zhiwei Zhang, et al.
ACS Nano|June 15, 2026
Self-Powered Smart Textiles for Accelerated Wound Healing through Band Alignment in Piezoelectric HeterojunctionsDi Zhang, Lingyun Guo, Haoping Xin, et al.
Gut|September 16, 2022
Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre studyQi Zhang, Mao Ye, Cheng Lin, et al.
Signal Transduction and Targeted Therapy|August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trialChuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYinghong Shi, Guohong Han, Jian Zhou, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
International Journal of Molecular Sciences|May 7, 2025
Environmental Factors Exacerbate Parkinsonian Phenotypes in an Asian-Specific Knock-In LRRK2 Risk Variant in MiceZoë Bichler, Sarivin Vanan, Zhiwei Zhang, et al.
ACS Nano|June 15, 2026
Self-Powered Smart Textiles for Accelerated Wound Healing through Band Alignment in Piezoelectric HeterojunctionsDi Zhang, Lingyun Guo, Haoping Xin, et al.
Gut|September 16, 2022
Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre studyQi Zhang, Mao Ye, Cheng Lin, et al.
Signal Transduction and Targeted Therapy|August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trialChuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYinghong Shi, Guohong Han, Jian Zhou, et al.
Pageof 20